These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19059940)

  • 1. Severe events in donors after allogeneic hematopoietic stem cell donation.
    Halter J; Kodera Y; Ispizua AU; Greinix HT; Schmitz N; Favre G; Baldomero H; Niederwieser D; Apperley JF; Gratwohl A
    Haematologica; 2009 Jan; 94(1):94-101. PubMed ID: 19059940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation in Europe 1998.
    Gratwohl A; Passweg J; Baldomero H; Hermans J; Urbano-Ispizua A;
    Hematol J; 2000; 1(5):333-50. PubMed ID: 11920211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors.
    Siddiq S; Pamphilon D; Brunskill S; Doree C; Hyde C; Stanworth S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006406. PubMed ID: 19160282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases.
    Anderlini P; Rizzo JD; Nugent ML; Schmitz N; Champlin RE; Horowitz MM; ;
    Bone Marrow Transplant; 2001 Apr; 27(7):689-92. PubMed ID: 11360107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.
    Watt SM; Austin E; Armitage S
    Methods Mol Biol; 2007; 368():237-59. PubMed ID: 18080475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
    Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
    Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies.
    Sohn SK; Jung JT; Kim DH; Lee NY; Seo KW; Chae YS; Park SW; Kim JG; Suh JS; Lee KB
    Cancer; 2002 Jan; 94(1):18-24. PubMed ID: 11815956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia.
    Bacigalupo A; Van Lint MT; Valbonesi M; Lercari G; Carlier P; Lamparelli T; Gualandi F; Occhini D; Bregante S; Valeriani A; Piaggio G; Pitto A; Benvenuto F; Figari O; De Stefano G; Caimo A; Sessarego M
    Blood; 1996 Jul; 88(1):353-7. PubMed ID: 8704195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Analysis of 37,287 Observation Years after Peripheral Blood Stem Cell Donation.
    Schmidt AH; Mengling T; Hernández-Frederick CJ; Rall G; Pingel J; Schetelig J; Ehninger G
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):1011-1020. PubMed ID: 28254417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
    Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-colony stimulating factor for hematopoietic stem cell donation from healthy female donors during pregnancy and lactation: what do we know?
    Pessach I; Shimoni A; Nagler A
    Hum Reprod Update; 2013; 19(3):259-67. PubMed ID: 23287427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Randomized clinical study for two types of recombinant human granulocyte colony-stimulating factor mobilizing peripheral blood and bone marrow stem cells in patients receiving allogeneic hematopoietic stem cell transplantation].
    Zhang XH; Huang XJ; Liu DH; Liu KY; Han W; Chen H; Wang FR; Chen YH; Wang JZ; Zhao T; Wang Y; Xu LP
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2116-9. PubMed ID: 20058615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation activity in Europe 1999.
    Gratwohl A; Passweg J; Baldomero H; Urbano-Ispizua A;
    Bone Marrow Transplant; 2001 May; 27(9):899-916. PubMed ID: 11436100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors].
    Zhang S; Jin H; Xu LP; Liu DH; Chen H; Liang YQ; Li T; Li FX; Wang R; Kang Q; Chen YH; Zhang XH; Han W; Huang XJ; Liu KY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1017-22. PubMed ID: 20723320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J; Brugger W; Bertz H; Behringer D; Kunzmann R; Weber-Nordt RM; Kanz L; Mertelsmann R
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).
    Halter JP; van Walraven SM; Worel N; Bengtsson M; Hägglund H; Nicoloso de Faveri G; Shaw BE; Schmidt AH; Fechter M; Madrigal A; Szer J; Aljurf MD; Weisdorf D; Horowitz MM; Greinix H; Niederwieser D; Gratwohl A; Kodera Y; Confer D
    Bone Marrow Transplant; 2013 Feb; 48(2):220-5. PubMed ID: 22773129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor.
    Bensinger WI; Weaver CH; Appelbaum FR; Rowley S; Demirer T; Sanders J; Storb R; Buckner CD
    Blood; 1995 Mar; 85(6):1655-8. PubMed ID: 7534140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications and donor source of hematopoietic stem cell transplants in Europe 1993: report from the European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Clin Transplant; 1995 Oct; 9(5):355-63. PubMed ID: 8541627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The incidence of malignancies and surveillance of hematopoietic stem cells donors--the results of the Haemato-Oncology Department University Hospital in Plzen (Pilsen) and Czech National Marrow Donors Registry observation].
    Vokurka S; Koza V; Jungová A; Navrátilová J; Svoboda T; Jindra P; Steinerová K; Hrabětová M; Výrutová R; Novák L
    Klin Onkol; 2012; 25(1):42-6. PubMed ID: 22348219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.